Sudarshan Pharma Industries Ltd acquired 10,000 shares of Sudarshan Singapore from Amar Ashok Vyas for SGD 10,000, fulfilling a prior disclosure. This acquisition, under SEBI's Regulation 30, establishes Sudarshan Singapore as a wholly-owned subsidiary of SPIL. This significantly expands SPIL's international presence. The stock gave multibagger returns of 467% from its 52-week low.